Global Classical Swine Fever Vaccines Market Growth 2025-2031

The global Classical Swine Fever Vaccines market size is predicted to grow from US$ 171 million in 2025 to US$ 226 million in 2031; it is expected to grow at a CAGR of 4.8% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).

The Classical Swine Fever (CSF) Vaccines market is driven by the urgent need to control and prevent outbreaks of CSF, a highly contagious viral disease that poses a major threat to the global swine industry. Governments and veterinary health organizations are implementing strict disease management and vaccination programs to safeguard animal health and ensure food security. Increased awareness among pig farmers, coupled with rising pork consumption worldwide, is accelerating the adoption of effective CSF vaccines. Furthermore, technological advancements in vaccine development, including the emergence of safer and more effective live attenuated and subunit vaccines, are supporting market growth.

Despite growing demand, the CSF Vaccines market faces several challenges, including inconsistent vaccination coverage and limited access to vaccines in low-resource regions. Inadequate cold chain infrastructure and weak veterinary healthcare systems in developing countries can hinder effective vaccine distribution and disease control. Additionally, the emergence of new CSF virus strains and the potential for incomplete immunity with certain vaccines pose ongoing risks. Regulatory hurdles and the need for continuous monitoring and updating of vaccine strains add further complexity. Addressing these issues requires coordinated international efforts, improved vaccine accessibility, and enhanced surveillance and biosecurity measures.

The global classical swine fever vaccine market is dominated by Winsun, Boehringer Ingelheim and CAHIC, with the top three manufacturers accounting for about 37% of the market share. Asia Pacific is the largest market for classical swine fever vaccines, with a market share of about 70%, followed by Europe with a market share of about 15%. Tissue Culture Origin is the main type, with a share about 66%. Market Sales is the main application, which holds a share about 95%.

LP Information, Inc. (LPI) ' newest research report, the “Classical Swine Fever Vaccines Industry Forecast” looks at past sales and reviews total world Classical Swine Fever Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Classical Swine Fever Vaccines sales for 2025 through 2031. With Classical Swine Fever Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Classical Swine Fever Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Classical Swine Fever Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Classical Swine Fever Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Classical Swine Fever Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Classical Swine Fever Vaccines and breaks down the forecast by Source, by Sales Channel, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Classical Swine Fever Vaccines.

This report presents a comprehensive overview, market shares, and growth opportunities of Classical Swine Fever Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by Source:
Tissue Culture Origin
Cell Line Origin

Segmentation by Sales Channel:
Government Tender
Market Sales

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
WINSUN
Merck
CAHIC
Tecon
SPAH
Boehringer Ingelheim
Ceva
Harbin Veterinary Research Institute
Qilu Animal Health Products Factory
Ringpu Biology
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP

Key Questions Addressed in this Report

What is the 10-year outlook for the global Classical Swine Fever Vaccines market?

What factors are driving Classical Swine Fever Vaccines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Classical Swine Fever Vaccines market opportunities vary by end market size?

How does Classical Swine Fever Vaccines break out by Source, by Sales Channel?

Please note: The report will take approximately 2 business days to prepare and deliver. Show more